About Topotecan Hydrochloride
            
            Class: | Antineoplastic agent, Topoisomerase I inhibitor  
Use: | Treatment of metastatic ovarian cancer, small cell lung cancer, and as a second-line therapy for certain types of cancer  
Adult dose: | 1.5 mg/m² IV infusion over 30 minutes once daily for 5 consecutive days, repeated every 21 days  
Pediatric dose: | Not established; use in pediatric patients should be based on clinical judgment and careful consideration of risks and benefits  
Side effects: | Nausea, vomiting, diarrhea, fatigue
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, Topoisomerase I inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of metastatic ovarian cancer, small cell lung cancer, and as a second-line therapy for certain types of cancer
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); protect from light; do not freeze
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Hospira Limited, UNITED KINGDOM
                    
                    
                    Package Size
                    4ml Glass Vial x 5
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 3068.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        1.5 mg/m² IV infusion over 30 minutes once daily for 5 consecutive days, repeated every 21 days
                    
                    
                        Pediatric Dose
                    
                    
                        Not established; use in pediatric patients should be based on clinical judgment and careful consideration of risks and benefits
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, diarrhea, fatigue, anemia, neutropenia, thrombocytopenia, alopecia
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to topotecan or any component of the formulation; patients with severely impaired bone marrow function
         
        
        
            
                Important Warnings
            
            Risk of myelosuppression; monitor blood counts regularly; may cause fetal harm; use caution in patients with renal impairment; avoid use in pregnancy unless necessary
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.